- Home
- CDT vs IPDN Comparison
CDT vs IPDN Comparison
Compare CDT & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- IPDN
- Stock Information
- Founded
- CDT 2019
- IPDN 2003
- Country
- CDT United States
- IPDN United States
- Employees
- CDT N/A
- IPDN N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- IPDN EDP Services
- Sector
- CDT Health Care
- IPDN Technology
- Exchange
- CDT Nasdaq
- IPDN Nasdaq
- Market Cap
- CDT 5.2M
- IPDN 5.4M
- IPO Year
- CDT N/A
- IPDN 2013
- Fundamental
- Price
- CDT $1.64
- IPDN $2.24
- Analyst Decision
- CDT
- IPDN
- Analyst Count
- CDT 0
- IPDN 0
- Target Price
- CDT N/A
- IPDN N/A
- AVG Volume (30 Days)
- CDT 95.0K
- IPDN 2.0M
- Earning Date
- CDT 08-26-2025
- IPDN 08-14-2025
- Dividend Yield
- CDT N/A
- IPDN N/A
- EPS Growth
- CDT N/A
- IPDN N/A
- EPS
- CDT N/A
- IPDN N/A
- Revenue
- CDT N/A
- IPDN $6,459,379.00
- Revenue This Year
- CDT N/A
- IPDN N/A
- Revenue Next Year
- CDT N/A
- IPDN N/A
- P/E Ratio
- CDT N/A
- IPDN N/A
- Revenue Growth
- CDT N/A
- IPDN N/A
- 52 Week Low
- CDT $1.61
- IPDN $0.97
- 52 Week High
- CDT $274.80
- IPDN $11.20
- Technical
- Relative Strength Index (RSI)
- CDT 29.41
- IPDN 51.04
- Support Level
- CDT $1.66
- IPDN $2.10
- Resistance Level
- CDT $1.85
- IPDN $2.27
- Average True Range (ATR)
- CDT 0.11
- IPDN 0.21
- MACD
- CDT 0.03
- IPDN -0.01
- Stochastic Oscillator
- CDT 8.36
- IPDN 54.64
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.